NDAORALTABLET
Approved
Dec 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
13
Data completeness
5/8 — Partial
AMBIEN (zolpidem tartrate) by Almatica Pharma is short-term treatment of insomnia through binding to the benzodiazepine site of α1 subunit containing gaba a receptors, increasing the frequency of chloride channel opening resulting in the inhibition of neuronal excitation. First approved in 1992.
Drug data last refreshed 10m ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMBIEN (zolpidem tartrate) is a short-acting sedative-hypnotic oral tablet approved in 1992 for the short-term treatment of insomnia. It works by binding to benzodiazepine receptors on GABA-A channels, increasing chloride influx and inhibiting neuronal excitation to promote sleep onset. The drug is indicated for patients with transient or chronic insomnia who struggle with sleep initiation.
$0.012BPart D
LOE ApproachingDeclining
Product is in late-stage lifecycle with modest Part D volume (~15K claims/year), signaling smaller brand teams and focus on defending remaining market share against generics.
Mechanism of Action
short-term treatment of insomnia through binding to the benzodiazepine site of α1 subunit containing GABA A receptors, increasing the frequency of chloride channel opening resulting in the inhibition of neuronal excitation.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (13)
A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies
Started Nov 2024
238 enrolled
Physician WorkflowArtificial Intelligence (AI)
Health Effects of Repeated Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Volunteers
Started May 2022
20 enrolled
Air Pollution
Astigmatism Correction With Intrastromal Arcuate Incisions in Eyes Undergoing Cataract Surgery With Femtosecond Laser Using the Cassini Ambient With Iris Registration (ARCUATAS)
Started Oct 2021
22 enrolled
CataractAstigmatism
Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Started Nov 2016
174 enrolled
Trypanosomiasis, AfricanSleeping SicknessTrypanosomiasis; Gambian
Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults
Started Sep 2016
62 enrolled
Health Effects of Ambient Air Pollution
Worked on AMBIEN at Almatica Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.